Literature DB >> 20864686

Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease.

Gabriel Contreras1, Bo Hu, Brad C Astor, Tom Greene, Thomas Erlinger, John W Kusek, Michael Lipkowitz, Julia A Lewis, Otelio S Randall, Lee Hebert, Jackson T Wright, Cynthia A Kendrick, Jennifer Gassman, George Bakris, Joel D Kopple, Lawrence J Appel.   

Abstract

In moderate and severe CKD, the association of cholesterol with subsequent cardiovascular disease (CVD) is weak. We examined whether malnutrition or inflammation (M-I) modifies the risk relationship between cholesterol levels and CVD events in African Americans with hypertensive CKD and a GFR between 20 and 65 ml/min per 1.73 m². We stratified 990 participants by the presence or absence of M-I, defined as body mass index <23 kg/m² or C-reactive protein >10 mg/L at baseline. The primary composite outcome included cardiovascular death or first hospitalization for coronary artery disease, stroke, or congestive heart failure occurring during a median follow-up of 77 months. Baseline total cholesterol (212 ± 48 versus 212 ± 44 mg/dl) and overall incidence of the primary CVD outcome (19 versus 21%) were similar in participants with (n = 304) and without (n = 686) M-I. In adjusted analyses, the CVD composite outcome exhibited a significantly stronger relationship with total cholesterol for participants without M-I than for participants with M-I at baseline (P < 0.02). In the non-M-I group, the cholesterol-adjusted hazard ratio (HR) for CVD increased progressively across cholesterol levels: HR = 1.19 [95% CI; 0.77, 1.84] and 2.18 [1.43, 3.33] in participants with cholesterol 200 to 239 and ≥240 mg/dl, respectively (reference: cholesterol <200). In the M-I group, the corresponding HRs did not vary significantly by cholesterol level. In conclusion, the presence of M-I modifies the risk relationship between cholesterol level and CVD in African Americans with hypertensive CKD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20864686      PMCID: PMC3014026          DOI: 10.1681/ASN.2009121285

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  47 in total

1.  In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products.

Authors:  L Diomede; D Albani; M Sottocorno; M B Donati; M Bianchi; P Fruscella; M Salmona
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-08       Impact factor: 8.311

Review 2.  The inflammation hypothesis and its potential relevance to statin therapy.

Authors:  James S Forrester; Peter Libby
Journal:  Am J Cardiol       Date:  2007-01-10       Impact factor: 2.778

3.  Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.

Authors:  J M Fernandez-Real; M Vayreda; C Richart; C Gutierrez; M Broch; J Vendrell; W Ricart
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

4.  Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation.

Authors:  Y Sato; Y Takatsu; K Kataoka; T Yamada; R Taniguchi; S Sasayama; A Matsumori
Journal:  Clin Cardiol       Date:  1999-12       Impact factor: 2.882

Review 5.  Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6?

Authors:  Peter Stenvinkel; Peter Barany; Olof Heimbürger; Roberto Pecoits-Filho; Bengt Lindholm
Journal:  Kidney Int Suppl       Date:  2002-05       Impact factor: 10.545

6.  Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.

Authors:  P Stenvinkel; O Heimbürger; F Paultre; U Diczfalusy; T Wang; L Berglund; T Jogestrand
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

7.  Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients.

Authors:  B Memoli; L Postiglione; B Cianciaruso; V Bisesti; C Cimmaruta; L Marzano; R Minutolo; V Cuomo; B Guida; M Andreucci; G Rossi
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

8.  Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.

Authors:  J Zimmermann; S Herrlinger; A Pruy; T Metzger; C Wanner
Journal:  Kidney Int       Date:  1999-02       Impact factor: 10.612

9.  Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition.

Authors:  Yongmei Liu; Josef Coresh; Joseph A Eustace; J Craig Longenecker; Bernard Jaar; Nancy E Fink; Russell P Tracy; Neil R Powe; Michael J Klag
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

10.  Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study.

Authors:  P Degoulet; M Legrain; I Réach; F Aimé; C Devriés; P Rojas; C Jacobs
Journal:  Nephron       Date:  1982       Impact factor: 2.847

View more
  12 in total

1.  CKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study of atherosclerosis.

Authors:  Julio A Lamprea-Montealegre; Brad C Astor; Robin L McClelland; Ian H de Boer; Gregory L Burke; Christopher T Sibley; Daniel O'Leary; A Richey Sharrett; Moyses Szklo
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-09       Impact factor: 8.237

2.  Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK).

Authors:  Teresa K Chen; Michelle M Estrella; Brad C Astor; Tom Greene; Xuelei Wang; Morgan E Grams; Lawrence J Appel
Journal:  Nephrol Dial Transplant       Date:  2015-03-27       Impact factor: 5.992

3.  Association of cholesterol levels with mortality and cardiovascular events among patients with CKD and different amounts of proteinuria.

Authors:  Szu-Chia Chen; Chi-Chih Hung; Yi-Chun Tsai; Jiun-Chi Huang; Mei-Chuan Kuo; Jia-Jung Lee; Yi-Wen Chiu; Jer-Ming Chang; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-08       Impact factor: 8.237

Review 4.  Protein-energy wasting and mortality in chronic kidney disease.

Authors:  Alice Bonanni; Irene Mannucci; Daniela Verzola; Antonella Sofia; Stefano Saffioti; Ezio Gianetta; Giacomo Garibotto
Journal:  Int J Environ Res Public Health       Date:  2011-05-19       Impact factor: 3.390

5.  Slow Physical Growth, Delayed Reflex Ontogeny, and Permanent Behavioral as Well as Cognitive Impairments in Rats Following Intra-generational Protein Malnutrition.

Authors:  Aijaz A Naik; Ishan K Patro; Nisha Patro
Journal:  Front Neurosci       Date:  2015-12-08       Impact factor: 4.677

6.  Association of Increased Serum Leptin with Ameliorated Anemia and Malnutrition in Stage 5 Chronic Kidney Disease Patients after Parathyroidectomy.

Authors:  Yao Jiang; Jingjing Zhang; Yanggang Yuan; Xiaoming Zha; Changying Xing; Chong Shen; Zhixiang Shen; Chao Qin; Ming Zeng; Guang Yang; Huijuan Mao; Bo Zhang; Xiangbao Yu; Bin Sun; Chun Ouyang; Xueqiang Xu; Yifei Ge; Jing Wang; Lina Zhang; Chen Cheng; Caixia Yin; Jing Zhang; Huimin Chen; Haoyang Ma; Ningning Wang
Journal:  Sci Rep       Date:  2016-06-16       Impact factor: 4.379

7.  Greater low-density lipoprotein cholesterol variability is associated with increased progression to dialysis in patients with chronic kidney disease stage 3.

Authors:  Yu-Hsuan Lin; Jiun-Chi Huang; Pei-Yu Wu; Szu-Chia Chen; Yi-Wen Chiu; Jer-Ming Chang; Hung-Chun Chen
Journal:  Oncotarget       Date:  2017-12-14

8.  Association of dyslipidemia with renal outcomes in chronic kidney disease.

Authors:  Szu-Chia Chen; Chi-Chih Hung; Mei-Chuan Kuo; Jia-Jung Lee; Yi-Wen Chiu; Jer-Ming Chang; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

9.  Aldosterone and mortality in hemodialysis patients: role of volume overload.

Authors:  Szu-Chun Hung; Yao-Ping Lin; Hsin-Lei Huang; Hsiao-Fung Pu; Der-Cherng Tarng
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

10.  Association of the variants and haplotypes in the DOCK7, PCSK9 and GALNT2 genes and the risk of hyperlipidaemia.

Authors:  Tao Guo; Rui-Xing Yin; Wei-Xiong Lin; Wei Wang; Feng Huang; Shang-Ling Pan
Journal:  J Cell Mol Med       Date:  2015-10-23       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.